Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index

Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases

(2013) Shu Zhang et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Quantitative Proteomic Analysis Identified Paraoxonase 1 as a Novel Serum Biomarker for Microvascular Invasion in Hepatocellular Carcinoma

(2013) Cheng Huang et al.   JOURNAL OF PROTEOME RESEARCH

Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer

(2013) Jung-Mo Ahn et al.   MOLECULAR & CELLULAR PROTEOMICS

Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients

(2012) Chun Sun et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Identification and Confirmation of Differentially Expressed Fucosylated Glycoproteins in the Serum of Ovarian Cancer Patients Using a Lectin Array and LC–MS/MS

(2012) Jing Wu et al.   JOURNAL OF PROTEOME RESEARCH

N-linked glycan changes of serum haptoglobin β chain in liver disease patients

(2011) Shu Zhang et al.   Molecular BioSystems

The three-gene paraoxonase family: Physiologic roles, actions and regulation

(2010) Louis-Philippe Précourt et al.   ATHEROSCLEROSIS

Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer

(2010) Hitoshi Matsumoto et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Glycoproteomics Analysis of Human Liver Tissue by Combination of Multiple Enzyme Digestion and Hydrazide Chemistry

(2009) Rui Chen et al.   JOURNAL OF PROTEOME RESEARCH

Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers

(2008) Miyako Nakano et al.   INTERNATIONAL JOURNAL OF CANCER